We provide you with 20 years of free, institutional-grade data for XERS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of XERS. Explore the full financial landscape of XERS stock.
| Reported Date | Ticker | Type | |
|---|---|---|---|
| 2021-08-05 | XERS | 10-Q | Url |
| 2021-05-13 | XERS | 10-Q | Url |
| 2021-03-09 | XERS | 10-K | Url |
| 2020-11-09 | XERS | 10-Q | Url |
| 2020-08-10 | XERS | 10-Q | Url |
| 2020-05-07 | XERS | 10-Q | Url |
| 2020-03-12 | XERS | 10-K | Url |
| 2019-11-07 | XERS | 10-Q | Url |
| 2019-08-06 | XERS | 10-Q | Url |
| 2019-05-09 | XERS | 10-Q | Url |
| 2019-03-06 | XERS | 10-K | Url |
| 2019-02-11 | XERS | S-1 | Url |
| 2018-11-08 | XERS | 10-Q | Url |
| 2018-08-14 | XERS | 10-Q | Url |
| 2018-05-24 | XERS | S-1 | Url |
Xeris Pharmaceuticals, Inc(NASDAQ:XERS) 
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes ready-to-use injectable and infusible drug formulations. Its proprietary XeriSol and XeriJect formulation technology platforms allow for the subcutaneous and intramuscular delivery of highly-concentrated, re...
Website: http://www.xerispharma.com
Founded: 2005
Full Time Employees: 172
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about XERS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.